Comparison of Polyhexamethylene Biguanide and Chlorhexidine as Monotherapy Agents in the Treatment of Acanthamoeba Keratitis

American Journal of Ophthalmology

Volumn 145, Issue 1, 2008, Pages 130-135

  Lim, Natasha ^a   Goh, David ^a   Bunce, Catey ^a   Xing, Wen ^a   Fraenkel, Graham ^a   Poole, Tom R G ^a   Ficker, Linda ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CHLORHEXIDINE; CYCLOPENTOLATE; DEXAMETHASONE; FLURBIPROFEN; POLY(HEXAMETHYLENEBIGUANIDE); PREDNISOLONE;

ACANTHAMOEBA KERATITIS; ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL TRIAL; CONTACT LENS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG TREATMENT FAILURE; EYE DISCOMFORT; FEMALE; HUMAN; KERATITIS; KERATOPATHY; KERATOPLASTY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCAR FORMATION; TISSUE CULTURE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY;

ACANTHAMOEBA KERATITIS; ADULT; BIGUANIDES; CHLORHEXIDINE; DISINFECTANTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 37249001292     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.08.040     Document Type: Article

References (28)

1. Duguid I.G., Dart J.K.G., Morlet N., et al. Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 104 (1997) 1587-1592
2. Lam D.S.C., Lyon D., Poon A.S.Y., Rao S.K., and Fan D.S. Polyhexamethylene biguanide (0.02%) alone is not adequate for treating chronic Acanthamoeba keratitis. Eye 14 (2000) 678-679
3. Kitagawa K., Nakamura T., and Takahashi N. A novel combination treatment of chlorhexidine gluconate, natamycin (pimaricin) and debridement for a Acanthamoeba keratitis. Jpn J Ophthalmol 47 (2003) 616-617
4. Kumar R., and Lloyd D. Recent advances in the treatment of Acanthamoeba keratitis. Clin Infect Dis 35 (2002) 434-441
5. Lee G.A., Gray T.B., Dart J.K.G., et al. Acanthamoeba sclerokeratitis: treatment with systemic immunosuppression. Ophthalmology 109 (2002) 1178-1182
6. Seal D.V. Acanthamoeba keratitis update-incidence, molecular epidemiology, and new drugs for treatment. Eye 17 (2003) 893-905
7. Narasimhan S., Madhavan H.N., and Therese L. Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamthylene biguanide and chlorhexidine. Cornea 21 (2002) 203-205
8. Wysenbeek Y.S., Blank-Porat D., Harizman N., Wygnanski-Jaffe T., Keller N., and Avni I. The reculture technique: individualizing the treatment of Acanthamoeba keratitis. Cornea 19 (2000) 464-467
9. Borazjani R.N., May L.L., Noble J.A., Avery S.V., and Ahearn D.G. Flow cytometry for determination of the efficacy of contact lens disinfecting solutions against Acanthamoeba spp. Appl Environ Microbiol 66 (2000) 1057-1061
10. Seal D.V., Hay J., and Kirkness C.M. Chlorhexidine or polyhexamthylene biguanide for Acanthamoeba keratitis. Lancet 345 (1995) 136
11. Seal D.V., Hay J., Kirkness C., et al. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 10 (1996) 413-421
12. Kosrirukvongs P., Wanachiwanawin D., and Visvesvara G.S. Treatment of Acanthamoeba keratitis with chlorhexidine. Ophthalmology 106 (1999) 798-802
13. Larkin D.F.P., Kilvington S., and Dart J.K.G. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 99 (1992) 185-191
14. Azuara-Blanco A., Sadiq A.S., Hussain M., Lloyd J.H., and Dua H.S. Successful medical treatment of Acanthamoeba keratitis. Int Ophthalmol 21 (1998) 223-227
15. Butler T.K., Males J.J., Robinson L.P., et al. Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002. Clin Experiment Ophthalmol 33 (2005) 41-46
16. Tseng S.H., Lin S.C., and Chen F.K. Is polyhexamethylene biguanide alone effective for Acanthamoeba keratitis?. Cornea 17 (1998) 345-346
17. Radford C.F., Lehmann O.J., and Dart J.K.G. Acanthamoeba keratitis: multicentre survey in England 1992-1996. Br J Ophthalmol 82 (1998) 1387-1392
18. Hay J., Kirkness C.M., Seal D.V., and Wright P. Drug resistance and Acanthamoeba keratitis: the quest for alternative protozoal chemotherapy. Eye 8 (1994) 555-563
19. Elder M.J., and Dart J.K.G. Chemotherapy for Acanthamoeba keratitis. Lancet 345 (1995) 791-792
20. D'Aversa G., Stern G.A., and Driebe Jr. W.T. Diagnosis and successful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol 113 (1995) 1120-1123
21. Lam D.S.C., Houang E., Fan D.S.P., Lyon D., Seal D., and Wong E. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye 16 (2002) 608-618
22. Hall R.C., and McKellar M.J. Bacterial keratitis in Christchurch, New Zealand, 1997-2001. Clin Experiment Ophthalmology 32 (2004) 478-481
23. Sharma S., Srinivasan M., and George C. Acanthamoeba keratitis in non-contact lens wearers. Arch Ophthalmol 108 (1990) 676-678
24. Chang P.C.T., and Soong H.K. Acanthamoeba keratitis in non-contact lens wearers [letter]. Arch Ophthalmol 109 (1991) 463-464
25. Chynn E.W., Lopez M.A., Pavan-Langston D., and Talamo J.H. Contact lens and non-contact lens characteristics. Ophthalmology 102 (1995) 1369-1373
26. Hirano K., and Sai S. Severe Acanthamoeba sclerokeratitis in a non-contact lens wearer. Acta Ophthalmol Scand 77 (1999) 347-348
27. Srinivasan M., Burman S., George C., and Nirmalan P.K. Non-contact lens related Acanthamoeba keratitis at a tertiary eye care centre in South India: implications for eye care programs in the region. Med Sci Monit 9 (2003) CR125-CR129
28. Kunimoto D.Y., Sharma S., Garg P., Gopinathan U., Miller D., and Rao G.N. Corneal ulcerations in the elderly in Hyderabad, South India. Br J Ophthalmol 84 (2000) 54-59